TY - JOUR
T1 - Isolating epidermal growth factor receptor overexpressing carcinoma cells from human whole blood by bio-ferrography
AU - Levi, Ofer
AU - Shapira, Assaf
AU - Tal, Baruch
AU - Benhar, Itai
AU - Eliaz, Noam
N1 - Publisher Copyright:
© 2014 International Clinical Cytometry Society.
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Background: The epidermal growth factor receptor (EGFR) is overexpressed in carcinoma. In some cases, including in colorectal cancer, it is used as a therapeutic target. Bio-Ferrography is a nondestructive method for isolating magnetized cells and tissues from a fluid onto a glass slide based on their interaction with an external, strong, and focused magnetic field. Methods: Here, we implement Bio-Ferrography to separate EGFR-positive cancer cells from EGFRnegative noncancer cells, mixed at a ratio of 1 to 1 × 106, from either phosphate-buffered saline or human whole blood. Incubation of the cells with an anti-EGFR antibody and magnetic microbeads coupled to a secondary antibody was used to magnetize the target cells prior to the ferrographic analysis. Results: A procedure was developed for "a proof of concept" isolation. Recovery values as high as 78% for 1 mL phosphate-buffered saline, and 53% for 1 mL human whole blood, with a limit-ofdetection of 30 and 100 target cells, respectively, were achieved. Conclusions: These capture efficiency values are considered significant and, therefore, warrant further study on isolation of real circulating tumor cells from blood samples of patients, aiming at early diagnosis of EGFR-overexpressing tumor types.
AB - Background: The epidermal growth factor receptor (EGFR) is overexpressed in carcinoma. In some cases, including in colorectal cancer, it is used as a therapeutic target. Bio-Ferrography is a nondestructive method for isolating magnetized cells and tissues from a fluid onto a glass slide based on their interaction with an external, strong, and focused magnetic field. Methods: Here, we implement Bio-Ferrography to separate EGFR-positive cancer cells from EGFRnegative noncancer cells, mixed at a ratio of 1 to 1 × 106, from either phosphate-buffered saline or human whole blood. Incubation of the cells with an anti-EGFR antibody and magnetic microbeads coupled to a secondary antibody was used to magnetize the target cells prior to the ferrographic analysis. Results: A procedure was developed for "a proof of concept" isolation. Recovery values as high as 78% for 1 mL phosphate-buffered saline, and 53% for 1 mL human whole blood, with a limit-ofdetection of 30 and 100 target cells, respectively, were achieved. Conclusions: These capture efficiency values are considered significant and, therefore, warrant further study on isolation of real circulating tumor cells from blood samples of patients, aiming at early diagnosis of EGFR-overexpressing tumor types.
KW - A431 cells
KW - Bio-Ferrography
KW - EGFR
KW - Human whole blood
KW - Immunomagnetic separation
KW - Monoclonal antibody
UR - http://www.scopus.com/inward/record.url?scp=84923692136&partnerID=8YFLogxK
U2 - 10.1002/cyto.b.21212
DO - 10.1002/cyto.b.21212
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84923692136
SN - 1552-4949
VL - 88
SP - 136
EP - 144
JO - Cytometry Part B - Clinical Cytometry
JF - Cytometry Part B - Clinical Cytometry
IS - 2
ER -